Sager G, Jaeger R, Little C
Department of Pharmacology, University of Tromsø, Norway.
Pharmacol Toxicol. 1989 Apr;64(4):365-8. doi: 10.1111/j.1600-0773.1989.tb00666.x.
Prazosin is extensively bound in human serum/plasma. In the present study a bound fraction of 93-95% was observed at 37 degrees for therapeutic drug concentrations. Both alpha 1-acid glycoprotein (AAG) and albumin (HSA) are established as transport proteins for prazosin, but their individual contribution to the extent and variability of protein binding in serum/plasma is unclear. The present study showed that AAG possesses one binding site per molecule with high affinity (Kd approximately 0.8 microM) for prazosin. HSA, essentially globulin-free, bound prazosin with lower affinity (Kd approximately 30 microM) with an average of 0.3 binding sites per molecule. However, less purified HSA, containing globulins, exhibited apparently higher affinity (Kd approximately 8 microM), but lower binding capacity (0.07 sites per molecule) for prazosin. In mixtures of highly purified proteins, the concentrations of AAG, and not HSA, determined the extent and variability of prazosin binding.
哌唑嗪在人血清/血浆中广泛结合。在本研究中,治疗药物浓度下,37摄氏度时观察到结合分数为93 - 95%。α1-酸性糖蛋白(AAG)和白蛋白(HSA)均被确认为哌唑嗪的转运蛋白,但它们对血清/血浆中蛋白质结合程度和变异性的各自贡献尚不清楚。本研究表明,AAG每个分子具有一个对哌唑嗪具有高亲和力(解离常数Kd约为0.8微摩尔)的结合位点。基本不含球蛋白的HSA以较低亲和力(Kd约为30微摩尔)结合哌唑嗪,每个分子平均有0.3个结合位点。然而,含有球蛋白的纯化程度较低的HSA对哌唑嗪表现出明显更高的亲和力(Kd约为8微摩尔),但结合能力较低(每个分子0.07个位点)。在高度纯化的蛋白质混合物中,决定哌唑嗪结合程度和变异性的是AAG的浓度,而非HSA的浓度。